Andira Pharmaceuticals Hires Eurofins Discovery to Further Develop Lead Asset
VANCOUVER, BC, May 31, 2022 – Andira Pharmaceuticals is proud to announce the hiring of Eurofins Discovery to conduct pre-clinical research on Andira’s lead asset, a cannabinoid-based injectable antibiotic for…
Comments Off on Andira Pharmaceuticals Hires Eurofins Discovery to Further Develop Lead Asset
May 31, 2022
